BCM
IPHS

BlueCrest Capital Management’s Innophos Holdings, Inc. IPHS Stock Holding History

BlueCrest Capital Management’s Portfolio IPHS Stock Details IPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,795
Closed -$235K – 1225
2019
Q1 		$235K Buy
+7,795
New +$234K 0.01% 857
2018
Q2 		– Sell
-7,275
Closed -$293K – 2011
2018
Q1 		$293K Buy
+7,275
New +$319K 0.01% 1073

Other funds holding IPHS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlueCrest Capital Management's IPHS Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Innophos Holdings, Inc. (IPHS) in Q2 2019, closing a stake of 7,795 shares — an estimated $235K sold.

BlueCrest Capital Management first reported a position in IPHS in Q1 2018 and held it in 2 quarters. The position peaked at $293K in Q1 2018. 149 funds tracked by Wall St. Rank hold IPHS as of Q2 2019.

  • BlueCrest Capital Management reported no remaining Innophos Holdings, Inc. position as of Q2 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 7,795 Innophos Holdings, Inc. shares in Q2 2019, an estimated $235K.
  • BlueCrest Capital Management first reported a position in Innophos Holdings, Inc. in Q1 2018 and held it in 2 quarters.
  • BlueCrest Capital Management's Innophos Holdings, Inc. position peaked at $293K in Q1 2018.
  • 149 funds tracked by Wall St. Rank held Innophos Holdings, Inc. as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.